Ovid Therapeutics (OVID) Q2 2023 Earnings

4AugConfirmed
Nov 22
Q4 2022
Q1 2023
Q2 2023
-0.21
-0.19
-0.18
-0.16

Details

Expected EPS
-0.2
Actual EPS
-0.18
Surprise EPS
0.02
Surprise Percent
+10%

Description

Ovid Therapeutics (OVID) has reported earnings of -0.18 per share for Q2 2023.

0 Comments

Share your thoughts